49843-98-3 | 6-Chloro-2,3,4,9-tetrahydro-1h-carbazole-1-carboxamide

Packsize	Purity	Availability	Price	Discounted Price
1mg	98%	in stock	$21.00	$15.00
5mg	≥98%	in stock	$42.00	$29.00
10mg	≥98%	in stock	$79.00	$55.00
25mg	95%	in stock	$142.00	$99.00
50mg	98%	in stock	$227.00	$159.00
100mg	98%	in stock	$354.00	$248.00
250mg	98%	in stock	$564.00	$395.00
1g	95%	in stock	$1,976.00	$1,383.00

Description

• Catalog Number: AG19670
• Chemical Name: 6-Chloro-2,3,4,9-tetrahydro-1h-carbazole-1-carboxamide
• CAS Number: 49843-98-3
• Molecular Formula: C13H13ClN2O
• Molecular Weight: 248.7081
• MDL Number: MFCD03009471
• SMILES: NC(=O)C1CCCc2c1[nH]c1c2cc(cc1)Cl

Computed Properties

• Complexity: 323
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 17
• Hydrogen Bond Acceptor Count: 1
• Hydrogen Bond Donor Count: 2
• Rotatable Bond Count: 1
• Undefined Atom Stereocenter Count: 1
• XLogP3: 2.5

Literature

• Embryoid body test with morphological and molecular endpoints implicates potential developmental toxicity of trans-resveratrol.

  Toxicology and applied pharmacology 20180915

• Inhibition of sirtuins 1 and 2 impairs cell survival and migration and modulates the expression of P-glycoprotein and MRP3 in hepatocellular carcinoma cell lines.

  Toxicology letters 20180601

• Salvianolic acid B protects against chronic alcoholic liver injury via SIRT1-mediated inhibition of CRP and ChREBP in rats.

  Toxicology letters 20170205

• Acute Treatment of Resveratrol Alleviates Doxorubicin-Induced Myotoxicity in Aged Skeletal Muscle Through SIRT1-Dependent Mechanisms.

  The journals of gerontology. Series A, Biological sciences and medical sciences 20160601

• Resveratrol via sirtuin-1 downregulates RE1-silencing transcription factor (REST) expression preventing PCB-95-induced neuronal cell death.

  Toxicology and applied pharmacology 20151101

• BET Inhibition Upregulates SIRT1 and Alleviates Inflammatory Responses.

  Chembiochem : a European journal of chemical biology 20150901

• Resveratrol improves hepatic steatosis by inducing autophagy through the cAMP signaling pathway.

  Molecular nutrition & food research 20150801

• Resveratrol activates duodenal Sirt1 to reverse insulin resistance in rats through a neuronal network.

  Nature medicine 20150501

• Resveratrol protects against doxorubicin-induced cardiotoxicity in aged hearts through the SIRT1-USP7 axis.

  The Journal of physiology 20150415

• A high-fat diet and NAD(+) activate Sirt1 to rescue premature aging in cockayne syndrome.

  Cell metabolism 20141104

• Discovery of potent and selective sirtuin 2 (SIRT2) inhibitors using a fragment-based approach.

  Journal of medicinal chemistry 20141023

• Non-specific SIRT inhibition as a mechanism for the cytotoxicity of ginkgolic acids and urushiols.

  Toxicology letters 20140902

• SIRT1 inhibition restores apoptotic sensitivity in p53-mutated human keratinocytes.

  Toxicology and applied pharmacology 20140615

• Des-acyl ghrelin protects microvascular endothelial cells from oxidative stress-induced apoptosis through sirtuin 1 signaling pathway.

  Metabolism: clinical and experimental 20140401

• Resveratrol attenuates the release of inflammatory cytokines from human bronchial smooth muscle cells exposed to lipoteichoic acid in chronic obstructive pulmonary disease.

  Basic & clinical pharmacology & toxicology 20140201

• Sesamin ameliorates doxorubicin-induced cardiotoxicity: involvement of Sirt1 and Mn-SOD pathway.

  Toxicology letters 20140113

• Resveratrol differentially regulates NAMPT and SIRT1 in Hepatocarcinoma cells and primary human hepatocytes.

  PloS one 20140101

• Resveratrol induces a mitochondrial complex I-dependent increase in NADH oxidation responsible for sirtuin activation in liver cells.

  The Journal of biological chemistry 20131220

• Resveratrol suppresses the STAT3 signaling pathway and inhibits proliferation of high glucose-exposed HepG2 cells partly through SIRT1.

  Oncology reports 20131201

• Resveratrol attenuates vascular endothelial inflammation by inducing autophagy through the cAMP signaling pathway.

  Autophagy 20131201

• Identification of potent Yes1 kinase inhibitors using a library screening approach.

  Bioorganic & medicinal chemistry letters 20130801

• Age-associated changes in gene expression and developmental competence of bovine oocytes, and a possible countermeasure against age-associated events.

  Molecular reproduction and development 20130701

• Resveratrol protects HUVECs from oxidized-LDL induced oxidative damage by autophagy upregulation via the AMPK/SIRT1 pathway.

  Cardiovascular drugs and therapy 20130601

• Discovery of thieno[3,2-d]pyrimidine-6-carboxamides as potent inhibitors of SIRT1, SIRT2, and SIRT3.

  Journal of medicinal chemistry 20130509

• SIRT1 inhibits NADPH oxidase activation and protects endothelial function in the rat aorta: implications for vascular aging.

  Biochemical pharmacology 20130501

• Resveratrol improves cardiomyopathy in dystrophin-deficient mice through SIRT1 protein-mediated modulation of p300 protein.

  The Journal of biological chemistry 20130222

• Resveratrol ameliorates ionizing irradiation-induced long-term hematopoietic stem cell injury in mice.

  Free radical biology & medicine 20130101

• Regulation of FOXOs and p53 by SIRT1 modulators under oxidative stress.

  PloS one 20130101

• Activation of SIRT1 protects pancreatic β-cells against palmitate-induced dysfunction.

  Biochimica et biophysica acta 20121101

• Role of deleted in breast cancer 1 (DBC1) protein in SIRT1 deacetylase activation induced by protein kinase A and AMP-activated protein kinase.

  The Journal of biological chemistry 20120706

• Design, synthesis, and biological activity of a novel series of human sirtuin-2-selective inhibitors.

  Journal of medicinal chemistry 20120628

• Sirt1 overexpression protects murine osteoblasts against TNF-α-induced injury in vitro by suppressing the NF-κB signaling pathway.

  Acta pharmacologica Sinica 20120501

• SIRT1 overexpression decreases cisplatin-induced acetylation of NF-κB p65 subunit and cytotoxicity in renal proximal tubule cells.

  Biochemical and biophysical research communications 20120309

• Resveratrol reverses monocrotaline-induced pulmonary vascular and cardiac dysfunction: a potential role for atrogin-1 in smooth muscle.

  Vascular pharmacology 20120101

• Nicotinamide phosphoribosyltransferase (Nampt) affects the lineage fate determination of mesenchymal stem cells: a possible cause for reduced osteogenesis and increased adipogenesis in older individuals.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20111101

• SIRT1 overexpression in the rheumatoid arthritis synovium contributes to proinflammatory cytokine production and apoptosis resistance.

  Annals of the rheumatic diseases 20111001

• SIRT1 activation by resveratrol ameliorates cisplatin-induced renal injury through deacetylation of p53.

  American journal of physiology. Renal physiology 20110801

• After the grape rush: sirtuins as epigenetic drug targets in neurodegenerative disorders.

  Bioorganic & medicinal chemistry 20110615

• The central Sirtuin 1/p53 pathway is essential for the orexigenic action of ghrelin.

  Diabetes 20110401

• Fructose induces gluconeogenesis and lipogenesis through a SIRT1-dependent mechanism.

  The Journal of endocrinology 20110301

• Resveratrol potentiates glucose-stimulated insulin secretion in INS-1E beta-cells and human islets through a SIRT1-dependent mechanism.

  The Journal of biological chemistry 20110225

• Measurement of the cellular deacetylase activity of SIRT1 on p53 via LanthaScreen® technology.

  Molecular bioSystems 20110101

• Sirtinol treatment reduces inflammation in human dermal microvascular endothelial cells.

  PloS one 20110101

• Resveratrol prevents RANKL-induced osteoclast differentiation of murine osteoclast progenitor RAW 264.7 cells through inhibition of ROS production.

  Biochemical and biophysical research communications 20101022

• SIRT1 modulates expression of matrix metalloproteinases in human dermal fibroblasts.

  The British journal of dermatology 20101001

• Acetylation of tau inhibits its degradation and contributes to tauopathy.

  Neuron 20100923

• Agrp neurons mediate Sirt1's action on the melanocortin system and energy balance: roles for Sirt1 in neuronal firing and synaptic plasticity.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20100901

• Early apoptotic vascular signaling is determined by Sirt1 through nuclear shuttling, forkhead trafficking, bad, and mitochondrial caspase activation.

  Current neurovascular research 20100501

• SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2.

  Molecular cancer therapeutics 20100401

• N(epsilon)-thioacetyl-lysine-containing tri-, tetra-, and pentapeptides as SIRT1 and SIRT2 inhibitors.

  Journal of medicinal chemistry 20090409

• Oxadiazole-carbonylaminothioureas as SIRT1 and SIRT2 inhibitors.

  Journal of medicinal chemistry 20080814

• Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage.

  Molecular and cellular biology 20060101

• Discovery of indoles as potent and selective inhibitors of the deacetylase SIRT1.

  Journal of medicinal chemistry 20051215

• The Sir2 family of protein deacetylases.

  Annual review of biochemistry 20040101